PMC:7102560 / 8343-8945 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T105","span":{"begin":51,"end":59},"obj":"Disease"},{"id":"T106","span":{"begin":70,"end":78},"obj":"Disease"},{"id":"T107","span":{"begin":70,"end":74},"obj":"Disease"},{"id":"T108","span":{"begin":189,"end":197},"obj":"Disease"},{"id":"T109","span":{"begin":189,"end":193},"obj":"Disease"},{"id":"T110","span":{"begin":266,"end":274},"obj":"Disease"},{"id":"T111","span":{"begin":266,"end":270},"obj":"Disease"},{"id":"T112","span":{"begin":345,"end":353},"obj":"Disease"},{"id":"T113","span":{"begin":354,"end":363},"obj":"Disease"},{"id":"T114","span":{"begin":405,"end":414},"obj":"Disease"},{"id":"T115","span":{"begin":567,"end":575},"obj":"Disease"}],"attributes":[{"id":"A105","pred":"mondo_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A108","pred":"mondo_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"We confirmed that in a significantly proportion of COVID-19 patients, SARS-CoV-2 reactivation developed after discharging from hospital (9%). We reported clinical data from 5 patients with SARS-CoV-2 reactivation. The clinical characteristics of these patients with SARS-CoV-2 reactivation were similar to those of non-reactivated patients with COVID-19 infection. None of the 5 patients developed severe pneumonia or died, as of Feb. 24, 2020. Notably, based on our findings in these 5 patients, there is currently evidence to suggest that a proportion of recovered COVID-19 patients could reactivate."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T70","span":{"begin":21,"end":22},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T71","span":{"begin":541,"end":542},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"We confirmed that in a significantly proportion of COVID-19 patients, SARS-CoV-2 reactivation developed after discharging from hospital (9%). We reported clinical data from 5 patients with SARS-CoV-2 reactivation. The clinical characteristics of these patients with SARS-CoV-2 reactivation were similar to those of non-reactivated patients with COVID-19 infection. None of the 5 patients developed severe pneumonia or died, as of Feb. 24, 2020. Notably, based on our findings in these 5 patients, there is currently evidence to suggest that a proportion of recovered COVID-19 patients could reactivate."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T41","span":{"begin":405,"end":414},"obj":"Phenotype"}],"attributes":[{"id":"A41","pred":"hp_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"We confirmed that in a significantly proportion of COVID-19 patients, SARS-CoV-2 reactivation developed after discharging from hospital (9%). We reported clinical data from 5 patients with SARS-CoV-2 reactivation. The clinical characteristics of these patients with SARS-CoV-2 reactivation were similar to those of non-reactivated patients with COVID-19 infection. None of the 5 patients developed severe pneumonia or died, as of Feb. 24, 2020. Notably, based on our findings in these 5 patients, there is currently evidence to suggest that a proportion of recovered COVID-19 patients could reactivate."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T115","span":{"begin":0,"end":141},"obj":"Sentence"},{"id":"T116","span":{"begin":142,"end":213},"obj":"Sentence"},{"id":"T117","span":{"begin":214,"end":364},"obj":"Sentence"},{"id":"T118","span":{"begin":365,"end":434},"obj":"Sentence"},{"id":"T119","span":{"begin":435,"end":444},"obj":"Sentence"},{"id":"T120","span":{"begin":445,"end":602},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We confirmed that in a significantly proportion of COVID-19 patients, SARS-CoV-2 reactivation developed after discharging from hospital (9%). We reported clinical data from 5 patients with SARS-CoV-2 reactivation. The clinical characteristics of these patients with SARS-CoV-2 reactivation were similar to those of non-reactivated patients with COVID-19 infection. None of the 5 patients developed severe pneumonia or died, as of Feb. 24, 2020. Notably, based on our findings in these 5 patients, there is currently evidence to suggest that a proportion of recovered COVID-19 patients could reactivate."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"290","span":{"begin":60,"end":68},"obj":"Species"},{"id":"291","span":{"begin":70,"end":80},"obj":"Species"},{"id":"292","span":{"begin":175,"end":183},"obj":"Species"},{"id":"293","span":{"begin":189,"end":199},"obj":"Species"},{"id":"294","span":{"begin":252,"end":260},"obj":"Species"},{"id":"295","span":{"begin":266,"end":276},"obj":"Species"},{"id":"296","span":{"begin":331,"end":339},"obj":"Species"},{"id":"297","span":{"begin":379,"end":387},"obj":"Species"},{"id":"298","span":{"begin":487,"end":495},"obj":"Species"},{"id":"299","span":{"begin":576,"end":584},"obj":"Species"},{"id":"300","span":{"begin":51,"end":59},"obj":"Disease"},{"id":"301","span":{"begin":345,"end":353},"obj":"Disease"},{"id":"302","span":{"begin":354,"end":363},"obj":"Disease"},{"id":"303","span":{"begin":405,"end":414},"obj":"Disease"},{"id":"304","span":{"begin":418,"end":422},"obj":"Disease"},{"id":"305","span":{"begin":567,"end":575},"obj":"Disease"}],"attributes":[{"id":"A290","pred":"tao:has_database_id","subj":"290","obj":"Tax:9606"},{"id":"A291","pred":"tao:has_database_id","subj":"291","obj":"Tax:2697049"},{"id":"A292","pred":"tao:has_database_id","subj":"292","obj":"Tax:9606"},{"id":"A293","pred":"tao:has_database_id","subj":"293","obj":"Tax:2697049"},{"id":"A294","pred":"tao:has_database_id","subj":"294","obj":"Tax:9606"},{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"Tax:2697049"},{"id":"A296","pred":"tao:has_database_id","subj":"296","obj":"Tax:9606"},{"id":"A297","pred":"tao:has_database_id","subj":"297","obj":"Tax:9606"},{"id":"A298","pred":"tao:has_database_id","subj":"298","obj":"Tax:9606"},{"id":"A299","pred":"tao:has_database_id","subj":"299","obj":"Tax:9606"},{"id":"A300","pred":"tao:has_database_id","subj":"300","obj":"MESH:C000657245"},{"id":"A301","pred":"tao:has_database_id","subj":"301","obj":"MESH:C000657245"},{"id":"A302","pred":"tao:has_database_id","subj":"302","obj":"MESH:D007239"},{"id":"A303","pred":"tao:has_database_id","subj":"303","obj":"MESH:D011014"},{"id":"A304","pred":"tao:has_database_id","subj":"304","obj":"MESH:D003643"},{"id":"A305","pred":"tao:has_database_id","subj":"305","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We confirmed that in a significantly proportion of COVID-19 patients, SARS-CoV-2 reactivation developed after discharging from hospital (9%). We reported clinical data from 5 patients with SARS-CoV-2 reactivation. The clinical characteristics of these patients with SARS-CoV-2 reactivation were similar to those of non-reactivated patients with COVID-19 infection. None of the 5 patients developed severe pneumonia or died, as of Feb. 24, 2020. Notably, based on our findings in these 5 patients, there is currently evidence to suggest that a proportion of recovered COVID-19 patients could reactivate."}